| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd, Inc. (TXMD) has 4 insiders with recent SEC Form 4 filings, including 8 buys and 5 sells. TXMD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 67.5K | $133.6K | - | |
| ? | 23.2K | $45.9K | - | |
| ? | 8.5K | $16.8K | - | |
| ? | 8.5K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2021 | Donegan Michael C85 | CAO And VP Finance | Sale+OE | 4,842 | $1.04 | $5,035.68 | -25.5% | -8.4% | -93.3% | |
| May 11, 2021 | Walker Marlan D81 | General Counsel | Sale+OE | 21,592 | $1.04 | $22,455.68 | -42.8% | -8.4% | -93.3% | |
| May 11, 2021 | Borkowski Edward | EVP, Operations | Sale+OE | 44,252 | $1.04 | $46,022.08 | -42.8% | -8.4% | -93.3% | |
| May 11, 2021 | Milligan John C.K. IV | Secretary/ CEO Of Subsidiary | Sale+OE | 44,252 | $1.04 | $46,022.08 | -2.5% | -8.4% | -93.3% | |
| May 11, 2021 | Finizio Robert G | CEO | Sale+OE | 67,697 | $1.04 | $70,404.88 | -0.4% | -8.4% | -93.3% | |
| Jun 9, 2020 | Finizio Robert G | CEO | Buy | 46,000 | $1.44 | $66,360.00 | +0.1% | - | - | |
| Jun 9, 2020 | Collins Cooper C. | Director | Buy | 74,000 | $1.45 | $107,300.00 | +46.7% | - | - | |
| Jun 5, 2020 | Finizio Robert G | CEO | Buy | 30,000 | $1.15 | $34,600.00 | - | - | - | |
| Jun 4, 2020 | Bisaro Paul | Director | Buy | 50,000 | $1.14 | $57,000.00 | New | - | - | |
| Jun 4, 2020 | Thompson Tommy G50 | Director | Buy | 8,700 | $1.13 | $9,831.00 | +1.3% | - | - |